Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials
Statistics in Medicine · 2025
DOI: 10.1002/sim.70297 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Jiaqi Tong and 4 co-authors. Institution: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. Major MEDLINE topics: Clinical Trials as Topic, Randomized Controlled Trials as Topic. 17 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (original language)
In clinical trials, the observation of participant outcomes may frequently be hindered by death, leading to ambiguity in defining a scientifically meaningful final outcome for those who die. Principal stratification methods are valuable tools for addressing the average causal effect among always‐survivors, that is, the average treatment effect among a subpopulation defined as those who would survive regardless of treatment assignment. Although robust methods for the truncation‐by‐death problem in two‐arm clinical trials have been previously studied, their expansion to multi‐arm clinical trials remains elusive. In this article, we study the identification of a class of survivor average causal effect estimands with multiple treatments under monotonicity and principal ignorability, and first propose simple weighting and regression approaches for point estimation. As a further improvement, we derive the efficient influence function to motivate doubly robust estimators for the survivor average causal effects in multi‐arm clinical trials. We also propose sensitivity methods under violations of key causal assumptions. Extensive simulations are conducted to investigate the finite‐sample performance of the proposed methods against the existing methods, and a real data example is used to illustrate how to operationalize the proposed estimators and the sensitivity methods in practice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
- Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, Connecticut, USA.
- Department of Statistics and Data Science, Washington University in St. Louis, St. Louis, Missouri, USA.
- Department of Internal Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID profiles: Jiaqi Tong, Guangyu Tong, Fan Li
Funding
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Cite
APA
Tong, J., Cheng, C., Tong, G., Harhay, M. O., & Li, F. (2025). Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials. Statistics in Medicine. https://doi.org/10.1002/sim.70297
Vancouver
Tong J, Cheng C, Tong G, Harhay MO, Li F. Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials. Statistics in Medicine. 2025. doi:10.1002/sim.70297
BibTeX
@article{Tong2025,
author = {Tong, Jiaqi and Cheng, Chao and Tong, Guangyu and Harhay, Michael O and Li, Fan},
title = {Doubly Robust Estimation and Sensitivity Analysis With Outcomes Truncated by Death in Multi‐Arm Clinical Trials},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70297}
}
EUVIMED